|Biotech Due Diligence||
The best of Bio-Twitter highlight what's new and notable in the scientific and medical literature.
For the second straight September, BiotechDueDiligence is recognizing Pediatric Cancer Awareness Month!
Researchers find a way to mimic clinical trials using genetics
Gary Taubes (MIT Technology Review)
The Secret Drug Pricing System Middlemen Use to Rake in Millions
Robert Langreth, David Ingold and Jackie Gu (Bloomberg)
Can mRNA disrupt the drug industry?
Ryan Cross (C&E News)
The Patients Who Don't Want to Be Cured
Sarah Zhang (The Atlantic)
I’m Coping With Cancer by Reporting On It
Alexandra Glorioso (Politico Magazine)
Cancer Rarely Strikes Elephants. New Clues Suggest Why.
Maya Wei-Haas (National Geographic)
Read on for a super-sized collection of scientific and medical journals driving the conversation on Twitter lately:
Anarchist Drugs For All. Yeahboy.
Derek Lowe (In the Pipeline)
A Rare Genetic Aversion to Sweets Could Be Key to Fighting Obesity
Jared S Hopkins (Bloomberg)
The 41% Man: Perceptive Advisors’ Joseph Edelman regularly crushes
markets and hedge fund peers. How?
Amanda Cantrell (Institutional Investor)
CVS decides to make ICER an American NICE
Jonathon Gardner (Vantage)
Early-Stage Biotech Value Creation: The Roles of Equity and Partnerships
Steve Holtzman (Leadership and Biotechnology)
The difficult search for the right recipe in cancer immunotherapy
Lisa M Jarvis (C&E News)
A Harvard Scientist Thinks He Has a Gene Test for Heart Attack Risk. He Wants to Give It Away Free.
Matthew Herper (Forbes)
Your support is greatly appreciated